Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.175 USD | -4.47% | -16.43% | -5.65% |
May. 09 | Transcript : Akebia Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Earnings Flash (AKBA) AKEBIA THERAPEUTICS Reports Q1 Revenue $32.6M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.65% | 258M | |
+7.83% | 111B | |
+11.18% | 106B | |
-12.21% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.77% | 16.81B | |
+38.51% | 12.54B | |
-24.46% | 8.09B |
- Stock Market
- Equities
- AKBA Stock
- News Akebia Therapeutics, Inc.
- Akebia Therapeutics : HC Wainwright & Co. Adjusts Price Target on Akebia Therapeutics to $6 From $9, Maintains Buy Rating